Media Room Menu
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Sep 28, 2017- First targeted biologic in the European Union to receive marketing authorization for use in atopic dermatitis -
-
Sep 16, 2017- Late-breaking oral abstract of Phase 3 CAFÉ study presented at the 26th European Academy of Dermatology and Venereology (EADV) Congress -
-
Jun 11, 2017- Data presented at the 77th Scientific Sessions of the American Diabetes Association (ADA) -
-
Jun 4, 2017- Oral presentation provides first REGN2810 data in patients with advanced cutaneous squamous cell carcinoma (CSCC) -
-
May 22, 2017- Kevzara is now available to U.S. patients -
-
May 11, 2017-- New Initiative Encourages Americans to Help Reduce Air Pollution & Enjoy the Outdoors this Spring Allergy Season --
-
Apr 28, 2017- New action date for Kevzara U.S. BLA is May 22, 2017 -
-
Apr 25, 2017- Monthly dosing schedule now approved in both United States and European Union -
-
Apr 24, 2017- New U.S. indication approved for Thymoglobulin [anti-thymocyte globulin (rabbit)]; first since 1998 -
-
Apr 3, 2017- New toothpaste introduced by the trusted leader in mouthwashes for more than 30 years helps motivate kids to brush their teeth -
-
Mar 28, 2017- Dupixent will be available later this week to U.S. patients suffering from this chronic and debilitating form of eczema -
-
Mar 21, 2017The makers of Xyzal® Allergy 24HR, now available over-the-counter (OTC) at full prescription strength, are teaming up with Dr. Neeta Ogden to Encourage Allergy Sufferers to 'Wise Up, Rise Up'
-
Mar 4, 2017- Late-breaking oral abstract to be presented today at the Annual Meeting of the American Academy of Dermatology -
-
Feb 8, 2017- Praluent continues to be available to patients in the U.S. -
-
Feb 1, 2017- Antihistamine Offers 24-Hour Relief to Adults and Children with Seasonal and Year-Round Allergies -
-
Nov 16, 2016- In the MONARCH Study, Sarilumab Monotherapy Demonstrated Superiority Over Adalimumab Monotherapy in Adults with Active Rheumatoid Arthritis -
-
Mar 4, 2016Praluent is now covered by most health insurance and Medicare plans